Skip to main content
SpringerLink
Log in

Plasma Level Monitoring of Anticonvulsants

  • Published:
Clinical Pharmacokinetics Aims and scope Submit manuscript

Summary

The plasma concentrations of anticonvulsant drugs, and of certain of their biologically active metabolites, tend to be proportionate to the antiepileptic effects of these drugs. Consequently, anticonvulsant drug levels in plasma are monitored to help guide the clinician in managing his patients’ epilepsies. In making use of the measurements, the clinician needs to know the relation between plasma level and biological effect for the various drugs. He also needs to have some awareness of simple pharmacokinetic principles. These are important in deciding when plasma levels should be monitored in relation to the patients’ clinical state, to the dosage interval, and to change in the dosage of anticonvulsant or other drug.

The clinician also requires pharmacokinetic knowledge in altering anticonvulsant drug dosage in his patients, and in interpreting plasma anticonvulsant level data, particularly when the patient is concurrently suffering from non-neurological disease. The ability to monitor plasma anticonvulsant levels has appreciably improved the treatment of epilepsy, but to obtain maximum benefits from the method, both pharmacokinetic insight and clinical wisdom are required.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Agurell, S.; Berlin, A.; Ferngren, H. and Hellstrom, B.: Plasma levels of diazepam after parenteral and rectal administration in children. Epilepsia (Amsterdam) 16: 277–283 (1975).

    Article  CAS  Google Scholar 

  • Albert, K.S.; Hallmark, M.R.; Carroll, M.E. and Wagner, J.G.: Quantitative separation of diphenylhydantoin and its para-hydroxylated metabolites by high-performance liquid chromatography. Research Communications in Chemical Pathology and Pharmacology 6: 845–854 (1973).

    PubMed  CAS  Google Scholar 

  • Arnold, K. and Gerber, N.: The rate of decline of diphenylhydantoin in human plasma. Clinical Pharmacology and Therapeutics 11: 121–134 (1970).

    PubMed  CAS  Google Scholar 

  • Atkinson, A.J. and Shaw, J.M.: Pharmacokinetic study of a patient with diphenylhydantoin toxicity. Clinical Pharmacology and Therapeutics 14: 521–528 (1973).

    PubMed  Google Scholar 

  • Atwell, S.H.; Green, V.A. and Harvey, W.G.: Development and evaluation of method for simultaneous determination of phenobarbital and diphenylhydantoin in plasma by high-pressure liquid chromatography. Journal of Pharmaceutical Sciences 64: 806–809 (1975).

    Article  PubMed  CAS  Google Scholar 

  • Barron, S.J.; Darcey, B.A. and Booker, H.E.: Metabolism and kinetics of methsuximide in man. Neurology (Minneapolis) 24: 386 (1974).

    Google Scholar 

  • Baumel, LP.; Gallagher, B.B. and Mattson, R.H.: Phenylethylmalonamide (PEMA). An important metabolite of primidone. Archives of Neurology (Chicago) 27: 34–41 (1972).

    Article  CAS  Google Scholar 

  • Blum, M.R.; Riegelman, S. and Becker, C.E.: Altered protein binding of diphenylhydantoin in uraemic plasma. New England Journal of Medicine 286: 109 (1972).

    PubMed  CAS  Google Scholar 

  • Bochner, F.; Hooper, W.D.; Sutherland, J.M.; Eadie, M.J. and Tyrer, J.H.: Diphenylhydantoin concentrations in saliva. Archives of Neurology (Chicago) 31: 57–59 (1974).

    Article  CAS  Google Scholar 

  • Bochner, F.; Hooper, W.D.; Tyrer, J.H. and Eadie, M.J.: The effect of dosage increments on blood phenytoin concentrations. Journal of Neurology, Neurosurgery and Psychiatry 35: 873–876 (1972).

    Article  CAS  Google Scholar 

  • Booker, H.E.: Trimethadione and other oxazolidinediones. Relation of plasma levels to clinical control; in Woodbury, Penry and Schmidt (Eds) Antiepileptic Drugs, p.403–407 (Raven Press, New York 1972).

    Google Scholar 

  • Booker, H.E. and Celesia, G.G.: Serum concentrations of diazepam in subjects with epilepsy. Archives of Neurology (Chicago) 29: 191–194 (1973).

    Article  CAS  Google Scholar 

  • Booker, H.E. and Darcey, B.: Serum concentrations of free diphenylhydantoin and their relationship to clinical intoxication. Epilepsia (Amsterdam) 14: 177–184 (1973).

    Article  CAS  Google Scholar 

  • Buchanan, R.A.; Fernandez, L. and Kinkel, A.W.: Absorption and elimination of ethosuximide in children. Journal of Clinical Pharmacology 9: 393–398 (1969).

    CAS  Google Scholar 

  • Buchanan, R.A.; Kinkel, A.W.; Goulet, J.R. and Smith, T.C.: The metabolism of diphenylhydantoin (Dilantin) following once-daily administration. Neurology (Minneapolis) 22: 126–130 (1972).

    Article  CAS  Google Scholar 

  • Buchanan, R.A.; Kinkel, A.W. and Smith, T.C.: The absorption and excretion of ethosuximide. International Journal of Clinical Pharmacology 7: 213–218 (1973).

    CAS  Google Scholar 

  • Buchthal, F. and Lennox-Buchthal, M.A.: Phenobarbital. Relation of serum concentration to control of seizures; in Woodbury, Penry and Schmidt (Eds) Antiepileptic Drugs, p.335–343 (Raven Press, New York 1972).

    Google Scholar 

  • Butler, T.C.: Metabolic demethylation of 3,5-dimethyl-5-ethyl 2,4-oxazolidinedione (paramethadione, Paradione®). Journal of Pharmacology and Experimental Therapeutics 113: 178–185 (1955).

    PubMed  CAS  Google Scholar 

  • Butler, T.C.: The metabolic conversion of 5,5-diphenylhydantoin to 5-(p-hydroxyphenyl)-5-phenyl-hydantoin. Journal of Pharmacology and Experimental Therapeutics 119: 1–11 (1957).

    PubMed  CAS  Google Scholar 

  • Chang, T.; Dill, W.A. and Glazko, A.J.: Ethosuximide. Absorption, distribution and excretion; in Woodbury, Penry and Schmidt (Eds) Antiepileptic Drugs, p.417–423 (Raven Press, New York 1972).

    Google Scholar 

  • Cotter, L.M.; Smith, G.A.; Hooper, W.D.; Tyrer, J.H. and Eadie, M.J.: The bioavailability of carbamazepine. Proceedings of the Australian Association of Neurologists 12: 123–128(1975).

    PubMed  CAS  Google Scholar 

  • Craig, C.R. and Shideman, F.E.: Metabolism and anticonvulsant properties of mephobarbital and phenobarbital in rats. Journal of Pharmacology and Experimental Therapeutics 176: 35–41 (1971).

    PubMed  CAS  Google Scholar 

  • De Silva, J.A.F. and Bekersky, I.: Determination of clonazepam and flunitrazepam in blood by electron-capture gas-liquid chromatography. Journal of Chromatography 99: 447–460 (1974).

    Article  PubMed  Google Scholar 

  • De Silva, J.A.F.; Puglisi, C.V. and Munro, N.: Determination of clonazepam and flunitrazepam in blood and urine by electron-capture GLC. Journal of Pharmaceutical Sciences 63: 520–527 (1974).

    Article  PubMed  Google Scholar 

  • Di Salle, E.; Pacifici, G.M. and Morselli, P.L.: Studies on plasma protein binding of carbamazepine. Pharmacology Research Communications 6: 193–202 (1974).

    Article  Google Scholar 

  • Dreifuss, F.E.; Penry, J.K.; Rose, S.W.; Kupferberg, H.J.; Dyken, P. and Sato, S.: Serum clonazepam concentrations in children with absence seizures. Neurology (Minneapolis) 25: 255–258 (1975).

    Article  CAS  Google Scholar 

  • Eadie, M.J. and Tyrer, J.H.: Anticonvulsant Therapy. Pharmacological Basis and Practice (Churchill Livingstone, Edinburgh 1974).

    Google Scholar 

  • Ehrsson, H.: Gas chromatographic determination of barbiturates after extractive methylation in carbon disulfide. Analytical Chemistry 46: 922–924 (1974).

    Article  PubMed  CAS  Google Scholar 

  • Ehrsson, H. and Tilly, A.: Electron capture gas chromatography of nitrazepam in human plasma as methyl derivative. Analytical Letters 6: 197–210 (1973).

    Article  CAS  Google Scholar 

  • Eichelbaum, M. and Bertilsson, L.: Determination of carbamazepine and its epoxide metabolite by high-speed liquid chromatography. Journal of Chromatography 103: 135–140(1975).

    Article  PubMed  CAS  Google Scholar 

  • Eichelbaum, M.; Ekbom, K.; Bertilsson, L.; Ringberger, V.A. and Rane, A.: Plasma pharmacokinetics of carbamazepine and its epoxide metabolite in man after single and multiple doses. European Journal of Clinical Pharmacology 8: 337–341 (1975).

    Article  PubMed  CAS  Google Scholar 

  • Evans, J.E.: Simultaneous measurement of diphenyl-hydantoin and phenobarbital in serum by high performance liquid chromatography. Analytical Chemistry 45: 2428–2429 (1973).

    Article  CAS  Google Scholar 

  • Firemark, H.; Barlow, C.F. and Roth, L.J.: The entry, accumulation and binding of diphenylhydantoin-2-C14 in brain. International Journal of Neuropharmacology 2:25–38 (1963).

    Article  CAS  Google Scholar 

  • Flynn, E.J. and Spector, S.: Determination of barbiturate derivatives by radioimmunoassay. Journal of Pharmacology and Experimental Therapeutics 181: 547–554 (1972).

    PubMed  CAS  Google Scholar 

  • Gallagher, B.B. and Baumel, L.P.: Primidone. Absorption, distribution and excretion; in Woodbury, Penry and Schmidt (Eds) Antiepileptic Drugs, p.357–359 (Raven Press, New York 1972).

    Google Scholar 

  • Gallagher, B.B. and Baumel, L.P.: Primidone — biotransformation; in Woodbury, Penry and Schmidt (Eds) Antiepileptic Drugs, p.361–366 (Raven Press, New York 1972).

    Google Scholar 

  • Gallagher, B.B.; Smith, D.B. and Mattson, R.H.: The relationship of the anticonvulsant properties of primidone to phenobarbital. Epilepsia (Amsterdam) 11: 293–301 (1970).

    Article  CAS  Google Scholar 

  • Garrettson, L.K. and Dayton, P.G.: Disappearance of phenobarbital and diphenylhydantoin from serum of children. Clinical Pharmacology and Therapeutics 11: 674–679 (1970).

    PubMed  CAS  Google Scholar 

  • Gauchel, G.; Gauchel, F.D. and Birkofer, L.: A micro-method for the determination of carbamazepine in blood by high speed liquid chromatography. Zeitschrift fur Klinische Chemie und Klinische Biochemie 11: 459–460 (1973).

    CAS  Google Scholar 

  • Gerber, N. and Wagner, J.G.: Explanation of the dose-dependent decline of diphenylhydantoin plasma levels by fitting to the integrated form of the Michaelis-Menten equation. Research Communications in Chemical Pathology and Pharmacology 3: 455–466 (1972).

    PubMed  CAS  Google Scholar 

  • Glazko, A.J. and Dill, W.A.: Other succinimides. Meth-suximide and phensuximide: in Woodbury, Penry and Schmidt (Eds) Antiepileptic Drugs, p.455–464 (Raven Press, New York 1972).

    Google Scholar 

  • Gouldie, J.H. and Burnett, D.: A gas-chromatographic method for the simultaneous determination of pheno-barbitone, primidone and phenytoin in serum using a nitrogen detector. Clinica Chimica Acta 43: 423–429 (1973).

    Article  Google Scholar 

  • Greeley, R.H.: New approach to derivatization and gas-chromatographic analysis of barbiturates. Clinical Chemistry 20: 192–194 (1974).

    PubMed  CAS  Google Scholar 

  • Haerer, A.F. and Buchanan, R.A.: Effectiveness of single daily doses of diphenylhydantoin. Neurology (Minneapolis) 22: 1021–1025 (1972).

    Article  CAS  Google Scholar 

  • Hauptmann, A.: Luminal bei Epilepsie. Munchener medizinische Wochenschrift 59: 1907–1909 (1912).

    Google Scholar 

  • Hooper, W.D.; Bochner, F.; Eadie, M.J. and Tyrer, J.H.: Plasma protein binding of diphenylhydantoin. Effects of sex hormones, renal and liver disease. Clinical Pharmacology and Therapeutics 15: 276–282 (1974).

    PubMed  CAS  Google Scholar 

  • Hooper, W.D.; Dubetz, D.K.; Bochner, F.; Cotter, L.M.; Smith, G.A.; Eadie, M.J. and Tyrer, J.H.: Plasma protein binding of carbamazepine. Clinical Pharmacology and Therapeutics 17: 433–440 (1975).

    PubMed  CAS  Google Scholar 

  • Hooper, W.D.; Dubetz, D.K.; Eadie, M.J. and Tyrer, J.H.: Preliminary observations on the clinical pharmacology of carbamazepine (’Tegretol’). Proceedings of the Australian Association of Neurologists 11: 189–198 (1974).

    PubMed  CAS  Google Scholar 

  • Horning, M.G.; Lertratanangkoon, K.; Nowlin, J.; Stillwell, W.G.; Stilwell, R.N.; Zion, T.E. and Kellaway, P.: Anticonvulsant drug monitoring by GC-MS-COM techniques. Journal of the Chromatographic Sciences 12: 630–635 (1974).

    CAS  Google Scholar 

  • Horning, M.G.; Stratton, C.; Nowlin, J.; Harvey, D.J. and Hill, R.M.: Metabolism of 2-ethyl-2-methylsuccinimide (Ethosuximide) in the rat and human. Drug Metabolism and Distribution 1: 569–576 (1973).

    CAS  Google Scholar 

  • Johannessen, S.I. and Strandjord, R.E.: Concentration of carbamazepine (Tegretol® in serum and cerebrospinal fluid in patients with epilepsy. Epilepsia (Amsterdam) 14: 373–379 (1973).

    Article  CAS  Google Scholar 

  • Kaplan, S.A.; Alexander, K.; Jack, M.L.; Puglisi, C.V.; de Silva, J.A.F.; Lee, T.L. and Weinfeld, R.E.: Pharmacokinetic profiles of clonazepam in dog and humans and of flunitrazepam in dog. Journal of Pharmaceutical Sciences 63: 527–532 (1974).

    Article  PubMed  CAS  Google Scholar 

  • Kaplan, S.A.; Jack, M.L.; Alexander, K. and Weinfeld, R.E.: Pharmacokinetic profile of diazepam in man following single intravenous and oral and chronic oral administrations. Journal of Pharmaceutical Sciences 62: 1789–1796 (1973).

    Article  PubMed  CAS  Google Scholar 

  • Knop, H.J.; Van der Kleijn, E. and Edmunds, L.C.: The determination of clonazepam in plasma by gas-liquid chromatography. Pharmaceutisch Weekblad 110: 297–309 (1975).

    CAS  Google Scholar 

  • Kutt, H.: Interactions of antiepileptic drugs. Epilepsia (Amsterdam) 16: 393–402 (1975).

    Article  CAS  Google Scholar 

  • Lander, C.M.; Edwards, V.E.; Eadie, M.J. and Tyrer, J.H.: Plasma anticonvulsant concentrations during pregnancy. Submitted for publication.

  • Lund, L.: Anticonvulsant effect of diphenylhydantoin relative to plasma levels. A prospective three-year study in ambulant patients with generalized epileptic seizures. Archives of Neurology (Chicago) 31: 289–294 (1974).

    CAS  Google Scholar 

  • Lund, L.; Berlin, A. and Lunde, P.K.M.: Plasma protein binding of diphenylhydantoin in patients with epilepsy. Agreement between the unbound fraction in plasma and the concentration in the cerebrospinal fluid. Clinical Pharmacology and Therapeutics 13: 196–200 (1972).

    CAS  Google Scholar 

  • Lund, M.: Failure to observe dosage instructions in patients with epilepsy. The short-term effect of a daily dispenser. Acta Neurologica Scandinavica 49: 295–306 (1973).

    CAS  Google Scholar 

  • Lund, M.; Jorgensen, R.S. and Kuhl, V.: Serum diphenylhydantoin (phenytoin) in ambulant patients with epilepsy. Epilepsia (Amsterdam) 5: 51–58 (1964).

    Article  CAS  Google Scholar 

  • Johannessen, S.I. and Strandjord, R.E.: The concentration of carbamazepine (Tegretol®) in serum and in cerebrospinal fluid in patients with epilepsy. Acta Neurologica Scandinavica 48 (Suppl. 51): 445–446 (1973).

    Google Scholar 

  • Mark, L.C.: Metabolism of barbiturates in man. Clinical Pharmacology and Therapeutics 4: 504–530 (1963).

    CAS  Google Scholar 

  • Mawer, G.E.; Mullen, P.W.; Rodgers, M.; Robins, A.J. and Lucas, S.B.: Phenytoin dose adjustment in epileptic patients. British Journal of Clinical Pharmacology 1: 163–168 (1974).

    Article  PubMed  CAS  Google Scholar 

  • Meijer, J.W.A.; Meinardi, H.; Gardner-Thorpe, C. and Van der Kleijn, E.: Methods of Analysis of Anti-epileptic Drugs (Excerpta Medica, Amsterdam, 1973).

    Google Scholar 

  • Meinardi, H.: Other antiepileptic drugs. Carbamazepine; in Woodbury, Penry and Schmidt (Eds) Antiepileptic Drugs, p.487–496 (Raven Press, New York 1972).

    Google Scholar 

  • Meinardi, H.: Discussion; in Meijer, Meinardi, Gardner Thorpe and Van der Kleijn (Eds) Methods of Analysis of Anti-epileptic Drugs, p. 211 (Excerpta Medica, Amsterdam 1973).

  • Meinardi, H.; Van der Kleijn, E.; Meijer, J.W.A. and Van Rees, H.: Absorption and distribution of antiepileptic drugs. Epilepsia (Amsterdam) 16: 353–365 (1975).

    Article  CAS  Google Scholar 

  • Montgomery, M.R.; Holtzman, J.L.; Leute, R.K.; Dewees, J.S. and Bolz, G.: Determination of diphenylhydantoin in human serum by spin immunoassay. Clinical Chemistry 21: 221–226 (1975).

    PubMed  CAS  Google Scholar 

  • Morrison, L.D. and O’Donnell, C.M.: Determination of diphenylhydantoin by phosphorescence spectrometry. Analytical Chemistry 46: 1119–1120 (1974).

    Article  PubMed  CAS  Google Scholar 

  • Morselli, P.L.: Discussion; in Meijer, Meinardi, Gardner Thorpe and Van der Kleijn (Eds) Methods of Analysis of Anti-epileptic Drugs, p. 175 (Excerpta Medica, Amsterdam 1973).

  • Morselli, P.L.; Principi, N.; Tognoni, G.; Reali, E.; Belvedere, G.; Standen, S.M. and Sereni, F.: Diazepam elimination in premature and full term infants, and children. Journal of Perinatal Medicine 1: 133–141 (1973).

    Article  PubMed  CAS  Google Scholar 

  • Müller, W. and Wollert, U.: Characterization of the binding of benzodiazepines to human serum albumin. Naunyn-Schmiedeberg’s Archives of Pharmacology 280: 229–237 (1973).

    Article  PubMed  Google Scholar 

  • Odar-Cederlöf, I.; Lunde, P. and Sjöqvist, F.: Abnormal pharmacokinetics of phenytoin in a patient with uraemia. Lancet 2: 831–832 (1970).

    Article  PubMed  Google Scholar 

  • Palmer, L.; Bertilsson, L.; Collste, P. and Rawlins, M.: Quantitative determination of carbamazepine in plasma by mass fragmentography. Clinical Pharmacology and Therapeutics 14: 827–832 (1973).

    PubMed  CAS  Google Scholar 

  • Peskar, B. and Spector, S.: Quantitative determination of diazepam in blood by radioimmunoassay. Journal of Pharmacology and Experimental Therapeutics 186: 167–172 (1973).

    PubMed  CAS  Google Scholar 

  • Randall, L.O.; Scheckel, C.L. and Banziger, R.: Pharmacology of the metabolites of chlordiazepoxide and diazepam. Current Therapeutic Research 1: 590–606 (1965).

    Google Scholar 

  • Reidenberg, M.M.; Odar-Cederlöf, I.; von Bahr, G.; Borgå, A. and Sjöqvist, F.: Protein binding of diphenylhydantoin and desmethylimipramine in plasma from patients with poor renal function. New England Journal of Medicine 285: 264–267 (1971).

    Article  PubMed  CAS  Google Scholar 

  • Richens, A.: Drug estimation in the treatment of epilepsy. Proceedings of the Royal Society of Medicine 67: 1227–1229 (1974).

    PubMed  CAS  Google Scholar 

  • Rieder, J. and Wendt, G.: Pharmacokinetics and metabolism of the hypnotic nitrazepam. Symposium on Benzodiazepines, Milan (1971).

    Google Scholar 

  • Rowan, A.J.; Pippenger, C.E.; McGregor, P.A. and French, J.H.: Seizure activity and anticonvulsant drug concentration. Archives of Neurology (Chicago) 32: 281–288 (1975).

    Article  CAS  Google Scholar 

  • Schobben, E.; Van der Kleijn, E. and Gabreels, F.J.M.: Pharmacokinetics of di-N-propylacetate in epileptic patients. European Journal of Clinical Pharmacology 8:97–105(1975).

    Article  PubMed  CAS  Google Scholar 

  • Sherwin, A.L. and Robb, J.P.: Ethosuximide: Relation of plasma level to clinical control; in Woodbury, Penry and Schmidt (Eds) Antiepileptic Drugs, p.443–448 (Raven Press, New York 1972).

    Google Scholar 

  • Shoeman, D.W. and Azarnoff, D.L.: The alteration of plasma proteins in uremia as reflected in their ability to bind digitoxin and diphenylhydantoin. Pharmacology 7: 169–177(1972).

    Article  PubMed  CAS  Google Scholar 

  • Spector, S. and Flynn, E.J.: Barbiturates: radioimmunoassay. Science 174: 1036–1038 (1971).

    Article  PubMed  CAS  Google Scholar 

  • Strandjord, R.E. and Johannessen, S.I.: One daily dose of diphenylhydantoin (DPH) to patients with epilepsy. Acta Neurologica Scandinavica 48 (Suppl 51): 499–500 (1972).

    Google Scholar 

  • Strandjord, R.E. and Johannessen, S.I.: One daily dose of diphenylhydantoin for patients with epilepsy. Epilepsia (Amsterdam) 15: 317–327 (1974).

    Article  CAS  Google Scholar 

  • Terrence, C.F. Jr.; Wisotzkey, H.M. and Perper, J.A.: Unexpected, unexplained death in epileptic patients. Neurology (Minneapolis) 25: 594–598 (1975).

    Article  Google Scholar 

  • Tigelaar, R.E.; Rapport, R.L. II; Inman, J.K. and Kupferberg, H.J.: A radioimmunoassay for diphenylhydantoin. dinica Chimica Acta 43: 231–241 (1973).

    Article  CAS  Google Scholar 

  • Triedman, H.M.; Fishman, R.A. and Yahr, M.D.: Determination of plasma and cerebrospinal fluid levels of Dilantin in the human. Transactions of the American Neurological Association 85: 166–170 (1960).

    PubMed  CAS  Google Scholar 

  • Troupin, A.S. and Friel, P.: Anticonvulsant level in saliva, serum, and cerebrospinal fluid. Epilepsia (Amsterdam) 16: 223–227 (1975).

    Article  CAS  Google Scholar 

  • Vajda, F.J.E.; Merory, J. and Bladin, P.F.: Fluctuations of plasma phenytoin levels on single dose and twice daily dose regimes. Proceedings of the Australian Association of Neurologists 12: 61–64 (1975).

    PubMed  CAS  Google Scholar 

  • Van der Kleijn, E.; Guellen, P.J.M.; Van Wijk, C.G.W.M.; Baars, I. and Vree, T.B.: Clinical pharmacokinetics of benzodiazepines, barbiturates and short chain fatty acids; in Levy (Ed) Clinical Pharmacokinetics, p.79–101 (American Pharmaceutical Association, Washington 1974).

    Google Scholar 

  • Van der Kleijn, E.; Van Rossum, J.M.; Muskens, E.T.J.M. and Rijntjes, N.V.M.: Pharmacokinetics of diazepam in dogs, mice and humans. Acta Pharmacologica et toxicologica 29 (Suppl. 3): 109–127 (1971).

    Google Scholar 

  • Venturella, V.S.; Gualario, V.M. and Lang, R.E.: Dimethyl-formamide diethylacetyl as a derivatizing agent for GLC of barbiturates and related compounds. Journal of Pharmaceutical Sciences 62: 662–668 (1973).

    Article  PubMed  CAS  Google Scholar 

  • Wallace, J.E.; Farquhar, J.K.; Hamilton, H.E. and Everhart, B.A.: Comments on the determination of diphenylhydantoin. Clinical Chemistry 20: 515–516 (1974).

    PubMed  CAS  Google Scholar 

  • Wechselberg, K. and Hubel, G.: Zur Resorption und Verteilung von Methyl-Althyl-Succinimid (MAS) im Serum und Liquor bei Kindern. Zeitschrift für Kinderheilkunde 100: 10–19(1967).

    Article  PubMed  CAS  Google Scholar 

  • Wilson, J.T. and Wilkinson, G.R.: Delivery of anticonvulsant drug therapy in epileptic patients assessed by plasma level analyses. Neurology (Minneapolis) 24: 614–623 (1974).

    Article  CAS  Google Scholar 

  • Wolf, S.M.; Carr, A.C.; Hanson, R.A.; Dale, E.P.; Davis, D.C.; Goldenberg, E.D.; Lulejian, G.A.; Sharpe, K.S.; Trietman, P. and Weinstein, A.W.: Parental compliance in the continuous administration of phenobarbital for the prevention of febrile seizures. Journal of Pediatrics 83: 1085–1086 (1973).

    Article  PubMed  CAS  Google Scholar 

  • Woodbury, D.M.; Penry, J.K. and Schmidt, R.: Antiepileptic Drugs (Raven Press, New York 1972).

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Medicine, University of Queensland, Clinical Sciences Building, Royal Brisbane Hospital, Brisbane, 4029, Australia

    M. J. Eadie

Authors
  1. M. J. Eadie
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Eadie, M.J. Plasma Level Monitoring of Anticonvulsants. Clin Pharmacokinet 1, 52–66 (1976). https://doi.org/10.2165/00003088-197601010-00005

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00003088-197601010-00005

Keywords

Search

Navigation